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Abstract
Background: Exacerbated oxidative stress is thought to be a mediator of arterial hypertension. It has been
postulated that creatine (Cr) could act as an antioxidant agent preventing increased oxidative stress. The aim of
this study was to investigate the effects of nine weeks of Cr or placebo supplementation on oxidative stress and
cardiovascular parameters in spontaneously hypertensive rats (SHR).
Findings: Lipid hydroperoxidation, one important oxidative stress marker, remained unchanged in the coronary
artery (Cr: 12.6 ± 1.5 vs. Pl: 12.2 ± 1.7 nmol·mg
-1; p = 0.87), heart (Cr: 11.5 ± 1.8 vs. Pl: 14.6 ± 1.1 nmol·mg
-1;p=
0.15), plasma (Cr: 67.7 ± 9.1 vs. Pl: 56.0 ± 3.2 nmol·mg
-1; p = 0.19), plantaris (Cr: 10.0 ± 0.8 vs. Pl: 9.0 ± 0.8 nmol·mg
-
1; p = 0.40), and EDL muscle (Cr: 14.9 ± 1.4 vs. Pl: 17.2 ± 1.5 nmol·mg
-1; p = 0.30). Additionally, Cr supplementation
affected neither arterial blood pressure nor heart structure in SHR (p > 0.05).
Conclusions: Using a well-known experimental model of systemic arterial hypertension, this study did not confirm
the possible therapeutic effects of Cr supplementation on oxidative stress and cardiovascular dysfunction
associated with arterial hypertension.
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Introduction
It has been suggested that exacerbated oxidative stress
and its consequent oxidative damage may be mediators
involved in cardiovascular diseases, such as systemic
arterial hypertension [1]. Supporting this notion, a
reduction in antioxidant bioavailability along with
increased oxidative stress has been reported in both
experimental and human hypertension [2].
Creatine (Cr) supplementation has emerged as a pro-
mising adjunct therapy in several pathological conditions
[3], including cardiovascular diseases [4,5]. Interestingly,
a growing body of experimental and clinical literature
has suggested that Cr may exert protective effect in dis-
eases where exacerbated oxidative stress plays a detri-
mental role (e.g., Huntington’s disease) [6-8]. In fact, in
vitro experiments have revealed that Cr may possess
antioxidant properties by acting as a scavenger of free
radicals, such as superoxide anions and peroxynitrite
[8,9]. For instance, Cr pre-loading was found to be cyto-
protective in different cell cultures with oxidative stres-
sors (i.e., H2O2, tBOOH and peroxynitrite) [10].
Moreover, Cr may also “indirectly” attenuate the forma-
tion of reactive oxygen species trough the coupling of
Cr with ATP into the mitochondria, ultimately resulting
in a more efficient mitochondrial respiration and
delayed accumulation of ADPf (i.e., the concentration of
unbound ADP in the cytoplasm), which has been impli-
cated in IMP and subsequently ROS formation [8,11].
This latter, in turn, may lead to oxidative stress with
formation of chemical products of ROS reactions, such
as oxidised glutathione and lipid hydroperoxides [12].
Despite the potential antioxidant capacity of Cr supple-
mentation, its effects on oxidative stress and,
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models of hypertension are still unknown.
This is a short-report on the effects of Cr supplemen-
tation on oxidative stress, heart structure, and arterial
blood pressure in spontaneously hypertensive rats
(SHR), a well-established experimental model of arterial
hypertension [13].
Material and methods
Procedures
This study was approved by the institution’se t h i c a l
committee and was conducted in accordance with the
National Research Council’s Guidelines for the Care and
Use of Laboratory Animals. Male SHR (26 weeks old)
were housed under controlled environmental conditions
(22°C; 12:12-h light:dark period) with free access to
commercial chow and water. Animals were randomly
allocated into two groups to receive either Cr (n = 8; 5
g/kg/d) or placebo (Pl; n = 7; distillated water). The
groups have similar body mass (Cr = 324.7 ± 41.9 vs. Pl
= 325.2 ± 21.6; p = 0.97). Cr monohydrate was adminis-
tered by gavage for nine weeks. Forty-eight hours after
the intervention, arterial blood pressure and heart rate
were invasively measured using a catheter inserted into
the femoral artery [14]. Thereafter, animals were killed
by decapitation. Plasma, heart, carotid artery, plantaris,
and extensor digitorum longus (EDL) muscles were iso-
lated, weighted and deep frozen at -80°C for further
analyses. Cardiomyocyte width and cardiac collagen
deposition were also assessed by histological analyses, as
measures of cardiac remodeling [15]. Additionally, lipid
hydroperoxidation (an important marker of oxidative
stress) was determined in the plasma, heart, carotid
artery, and skeletal muscles. These aforementioned
methods have been described in details below.
Hemodynamic parameters
After an intra-peritoneal anesthetic injection (80 mg/kg
ketamine and 12 mg/kg xylazine, i.p.), a catheter filled
with 0.06 mL of saline was inserted into the femoral
artery of rats. Twenty four hours after the catheter
insertion, the arterial cannula was connected to a strain-
gauge transducer (Blood Pressure XDCR; Kent Scienti-
fic, Torrington, CT, USA), and arterial pressure signals
were recorded over a 30 min period in conscious rats by
a microcomputer equipped with an analog-to-digital
converter board (WinDaq, 2 kHz, DATAQ, Springfield,
OH, USA). The recorded data were analyzed on a beat-
to-beat basis to quantify systolic, diastolic and mean
arterial pressure, as well as heart rate.
Histological analyses
Cardiac chambers were fixed by immersion in 4% buf-
fered formalin and embedded in paraffin for routine
histologic processing. Sections (4 μm) were stained with
hematoxylin and eosin for examination by light micro-
scopy. Only nucleated cardiac myocytes from areas of
transversely cut muscle fibers were included in the ana-
lysis. Quantification of left ventricular fibrosis was
achieved by Sirius red staining. Cardiac myocyte width
and ventricular fibrosis were measured in the LV free
wall with a computer assisted morphometric system
(Leica Quantimet 500, Cambridge, UK).
Lipid hydroperoxidation measurement
Lipid hydroperoxidation was assessed since this oxidative
stress marker has been implicated in the pathogenesis of a
number of cardiovascular diseases, including arterial
hypertension [16,17]. Lipid hydroperoxides were evaluated
by the ferrous oxidation-xylenol orange technique (FOX2)
[18]. Plasma, Heart, Carotid Artery, Plantar and EDL sam-
ples were homogenized in phosphate-buffered saline (PBS;
100 mmol/L, pH 7.4) and immediately centrifuged at
12.000 g for 20 min at 4°C. The homogenate was precipi-
tated with trichloroacetic acid (10% w/v) and centrifuged
(12.000 g for 20 min at 4°C). Supernatant was mixed with
FOX reagent (250 mmol/L ammonium ferrous sulfate, 100
mmol/L xylenol orange, 25 mmol/L H2SO4 and 4 mmol/
L BHT in 90% methanol) and incubated at room tempera-
ture for 20 min. The absorbance of the sample was read at
560 nm in a spectrophotometer.
Statistical analysis
Data are expressed as mean ± standard error. The
dependent variables were tested by unpaired Student’s t
test. Cohen’s d effect size (Cr group minus placebo
group divided by the standard deviation pooled) was
also calculated for dependent variables. The level of sig-
nificance was previously set at p < 0.05.
Results
As shown in Table 1, there were no significant differ-
ences in hemodynamic parameters between groups fol-
lowing the intervention.
Additionally, no significant differences between groups
were shown in heart weight, cardiomyocyte width, and
cardiac collagen content (Table 2). Lipid hydroperoxida-
tion also remained unchanged in the coronary artery,
heart, plasma, plantaris, and EDL (Table 3).
Comments
Cr intake failed to attenuate oxidative stress in the car-
diovascular system (i.e., heart and artery) as well in
other tissues (i.e., plasma and skeletal muscle) in SHR.
Furthermore, Cr did not affect either the heart structure
or the hemodynamic parameters. Altogether, these data
suggest that Cr supplementation does not exert thera-
peutically relevant effects in a model of SHR.
Alves et al. Journal of the International Society of Sports Nutrition 2012, 9:13
http://www.jissn.com/content/9/1/13
Page 2 of 4It has been speculated that the coupling of Cr with
ATP into the mitochondria could attenuate the forma-
tion of reactive oxygen species by stimulating the
r e s p i r a t i o nr a t ea n dr e d u c i n gt h ef r e ee n e r g yr e q u i r e d
for ATP synthesis [8]. Furthermore, Cr appears to act as
a direct scavenger of radical species in face of oxidative
stress [8,9]. These in vitro antioxidant proprieties confer
to Cr a possible therapeutic role in diseases in which
oxidative stress is exacerbated and related to pathologi-
cal conditions. However, the current results were in
contrast to our hypothesis. There are two potential
speculations for the lack of any “positive” outcome in
this study. First, the arterial blood pressure peaks at 24
weeks of age in SHR [13]. Therefore, one may assume -
despite the lack of a healthy control group - that our
rats displayed severe arterial hypertension. In such
extreme conditions, Cr may be not capable of reverting
cardiovascular dysfunction. Second, Cr metabolism is
divergent among species [19], meaning that the in vitro
antioxidant effects of Cr may not be extended to in vivo
models. Further studies with other experimental models
of hypertension as well as randomized controlled trials
with humans are required to determine whether Cr sup-
plementation can alleviate oxidative stress and cardio-
vascular dysfunction in arterial hypertension.
In summary, Cr supplementation did not affect oxida-
tive stress or cardiovascular parameters in SHR model.
Abbreviations
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